A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4


Journal

Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R

Informations de publication

Date de publication:
01 02 2021
Historique:
received: 09 07 2020
accepted: 16 11 2020
pubmed: 11 12 2020
medline: 30 1 2021
entrez: 10 12 2020
Statut: ppublish

Résumé

Gaining detailed insights into the role of host immune responses in viral clearance is critical for understanding COVID-19 pathogenesis and future treatment strategies. Although studies analyzing humoral immune responses against SARS-CoV-2 were available rather early during the pandemic, cellular immunity came into focus of investigations just recently. For the present work, we have adapted a protocol designed for the detection of rare neoantigen-specific memory T cells in cancer patients for studying cellular immune responses against SARS-CoV-2. Both CD4

Identifiants

pubmed: 33298615
pii: jimmunol.2000811
doi: 10.4049/jimmunol.2000811
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

580-587

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 by The American Association of Immunologists, Inc.

Auteurs

Henning Zelba (H)

CeGaT GmbH, 72076 Tübingen, Germany; and henning.zelba@cegat.de.

David Worbs (D)

CeGaT GmbH, 72076 Tübingen, Germany; and.

Johannes Harter (J)

CeGaT GmbH, 72076 Tübingen, Germany; and.

Natalia Pieper (N)

CeGaT GmbH, 72076 Tübingen, Germany; and.

Christina Kyzirakos-Feger (C)

Praxis fuer Humangenetik, 72076 Tübingen, Germany.

Simone Kayser (S)

Praxis fuer Humangenetik, 72076 Tübingen, Germany.

Marcel Seibold (M)

Praxis fuer Humangenetik, 72076 Tübingen, Germany.

Oliver Bartsch (O)

Praxis fuer Humangenetik, 72076 Tübingen, Germany.

Jiri Ködding (J)

CeGaT GmbH, 72076 Tübingen, Germany; and.

Saskia Biskup (S)

Praxis fuer Humangenetik, 72076 Tübingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH